Countries citing scholars working at South Texas Accelerated Research Therapeutics
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at South Texas Accelerated Research Therapeutics. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at South Texas Accelerated Research Therapeutics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites South Texas Accelerated Research Therapeutics more than expected).
Fields of papers published by authors at South Texas Accelerated Research Therapeutics
This network shows the impact of papers affiliated with South Texas Accelerated Research Therapeutics at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with South Texas Accelerated Research Therapeutics at the time of their publication.
About South Texas Accelerated Research Therapeutics
In recent decades, authors affiliated with South Texas Accelerated Research Therapeutics have published 531 papers, which have received a total of 24.0k indexed citations . Scholars at this organization have produced 218 papers in Oncology, 95 papers in Pulmonary and Respiratory Medicine, 31 papers in Genetics, 39 papers in Cancer Research and 50 papers in Radiology, Nuclear Medicine and Imaging on the topics of Cancer Immunotherapy and Biomarkers (90 papers), Lung Cancer Treatments and Mutations (42 papers), Monoclonal and Polyclonal Antibodies Research (36 papers), CAR-T cell therapy research (34 papers), HER2/EGFR in Cancer Research (32 papers), Cancer Genomics and Diagnostics (26 papers), Colorectal Cancer Treatments and Studies (22 papers) and Cancer Treatment and Pharmacology (22 papers). Their work is cited by papers focused on Oncology (9.5k citations), Cancer Research (2.5k citations), Immunology (3.7k citations), Pulmonary and Respiratory Medicine (3.9k citations) and Molecular Biology (8.3k citations). Authors at South Texas Accelerated Research Therapeutics collaborate with scholars in United States, Spain and Australia and have published in prestigious journals including Annals of Oncology, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology and Blood. Some of South Texas Accelerated Research Therapeutics's most productive authors include Anthony W. Tolcher, Amita Patnaik, Kyriakos P. Papadopoulos, Antoni Ribas, Jeremy D. Heidel, Jonathan E. Zuckerman, Mark E. Davis, Yun Yen, David B. Seligson and Christopher A. Alabi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact